Clinical Trial Update: Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on safety and efficacy of PNEUMOSTEM in premature infants at high risk for bronchopulmonary dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• PNEUMOSTEM

Snippet

Sponsor: Medipost, Inc. | Conditions: Bronchopulmonary Dysplasia | Phase 1, Phase 2 | Status: COMPLETED